𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuropsychological profile of Alzheimer’s disease in women: moderate and moderately severe cognitive decline

✍ Scribed by J. Garre-Olmo; S. López-Pousa; J. Vilalta-Franch; A. Turon-Estrada; M. Lozano-Gallego; M. Hernández-Ferràndiz; E. Gelada-Batlle; M. M. Cruz-Reina; V. Morante-Muñoz; J. Peralta-Rodríguez

Publisher
Springer Vienna
Year
2004
Tongue
English
Weight
301 KB
Volume
7
Category
Article
ISSN
1434-1816

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of rivastigmine in subjects wit
Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease
✍ A. Burns; R. Spiegel; P. Quarg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## Background Cholinesterase (ChE) inhibitors are primarily used in the treatment of mild to moderate Alzheimer's disease (AD), but may also be effective in more severe disease. ## Objective To evaluate the dual ChE inhibitor, rivastigmine, in more severe dementia. ## Methods We re

Progression in alzheimer's disease: Sequ
Progression in alzheimer's disease: Sequencing of neuropsychological decline
✍ Ove Almkvist; Lars Bäckman 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

## Abstract The progression of cognitive and motor functions in Alzheimer's disease (AD) patients and healthy aged individuals was studied. For the healthy aged, the progress was negligible during a 2‐year period. In the AD patients, there was a marked progression in all cognitive tests, but only a

Homocysteine as a predictor of cognitive
Homocysteine as a predictor of cognitive decline in Alzheimer's disease
✍ Abderrahim Oulhaj; Helga Refsum; Helen Beaumont; Jonathan Williams; Elizabeth Ki 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 1 views

## Abstract ## Objective Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established A

Tolerability of switching from donepezil
Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease
✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving